How can companies successfully engage with stakeholders to support better access to treatment for patients? In this Pharmaceutical Executive article, Andrew Butcher and Brian Kennedy, Executive Director of Alliance for Patient Access, outline six steps that help maximize the prospects for success in light of the evolving dynamics in stakeholder relationships.
Click here to read the article.
NCDs & long-term antimicrobial therapy
1 in 4 people globally are already affected by NCDs. By 2030, NCDs will cause 55 million deaths per year under ‘business as usual.’1,2 Effective...